78 related articles for article (PubMed ID: 24241721)
1. Dose-response modeling of etoposide-induced DNA damage response.
Li Z; Sun B; Clewell RA; Adeleye Y; Andersen ME; Zhang Q
Toxicol Sci; 2014 Feb; 137(2):371-84. PubMed ID: 24241721
[TBL] [Abstract][Full Text] [Related]
2. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
3. Contribution of ATM and ATR kinase pathways to p53-mediated response in etoposide and methyl methanesulfonate induced DNA damage.
Sun B; Ross SM; Rowley S; Adeleye Y; Clewell RA
Environ Mol Mutagen; 2017 Mar; 58(2):72-83. PubMed ID: 28195382
[TBL] [Abstract][Full Text] [Related]
4. DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.
MacFarlane M; Jones NA; Dive C; Cohen GM
Mol Pharmacol; 1996 Oct; 50(4):900-11. PubMed ID: 8863836
[TBL] [Abstract][Full Text] [Related]
5. Numerical analysis of etoposide induced DNA breaks.
Muslimović A; Nyström S; Gao Y; Hammarsten O
PLoS One; 2009 Jun; 4(6):e5859. PubMed ID: 19516899
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.
Chresta CM; Masters JR; Hickman JA
Cancer Res; 1996 Apr; 56(8):1834-41. PubMed ID: 8620501
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of myeloperoxidase activity have impact on the formation of DNA double-strand breaks induced by etoposide in HL-60 cell line.
Papież MA; Krzyściak W; Wąsik M
Folia Med Cracov; 2015; 55(1):43-51. PubMed ID: 26774631
[TBL] [Abstract][Full Text] [Related]
8. Effects of four chemotherapeutic agents, bleomycin, etoposide, cisplatin, and cyclophosphamide, on DNA damage and telomeres in a mouse spermatogonial cell line.
Liu M; Hales BF; Robaire B
Biol Reprod; 2014 Apr; 90(4):72. PubMed ID: 24571982
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
[TBL] [Abstract][Full Text] [Related]
10. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
11. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage.
Schonn I; Hennesen J; Dartsch DC
Apoptosis; 2010 Feb; 15(2):162-72. PubMed ID: 20041303
[TBL] [Abstract][Full Text] [Related]
12. Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage.
Clewell RA; Sun B; Adeleye Y; Carmichael P; Efremenko A; McMullen PD; Pendse S; Trask OJ; White A; Andersen ME
Toxicol Sci; 2014 Nov; 142(1):56-73. PubMed ID: 25078064
[TBL] [Abstract][Full Text] [Related]
13. The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway.
Ayed-Boussema I; Bouaziz C; Rjiba K; Valenti K; Laporte F; Bacha H; Hassen W
Toxicol In Vitro; 2008 Oct; 22(7):1671-80. PubMed ID: 18662769
[TBL] [Abstract][Full Text] [Related]
14. The aging effect of chemotherapy on cultured human mesenchymal stem cells.
Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C
Exp Hematol; 2011 Dec; 39(12):1171-81. PubMed ID: 21864489
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Assessment of modulated cytostatic drug resistance by automated γH2AX analysis.
Reddig A; Lorenz S; Hiemann R; Guttek K; Hartig R; Heiserich L; Eberle C; Peters V; Schierack P; Sack U; Roggenbuck D; Reinhold D
Cytometry A; 2015 Aug; 87(8):724-32. PubMed ID: 25845327
[TBL] [Abstract][Full Text] [Related]
17. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
19. Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells.
Wozniak K; Gloc E; Morawiec Z; Blasiak J
Exp Oncol; 2008 Mar; 30(1):22-8. PubMed ID: 18438337
[TBL] [Abstract][Full Text] [Related]
20. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
